NCT05334719View on ClinicalTrials.gov

A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

June 29, 2022

Primary Completion Date

January 16, 2026

Study Completion Date

September 30, 2026

Conditions
Stomach Neoplasms
Trial Locations (1)

1050001

Local Institution - 0001, Minato-ku

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY